Vaisitti T - Search Results

1

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

Vaisitti T, Arruga F, Vitale N, Lee TT, Ko M, Chadburn A, Braggio E, Di Napoli A, Iannello A, Allan JN, Miller LL, Lannutti BJ, Furman RR, Jessen KA, Deaglio S. Vaisitti T, et al. Blood. 2021 Jun 17;137(24):3365-3377. doi: 10.1182/blood.2020008404. Blood. 2021. PMID: 33512452 Free PMC article.

2

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.

Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L, Boumsell L, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Blood. 2005 Apr 15;105(8):3042-50. doi: 10.1182/blood-2004-10-3873. Epub 2004 Dec 21. Blood. 2005. PMID: 15613544 Free article.

3

CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells.

Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, Vaisitti T, Malavasi F, Ausiello CM. Frasca L, et al. Among authors: vaisitti t. Blood. 2006 Mar 15;107(6):2392-9. doi: 10.1182/blood-2005-07-2913. Epub 2005 Nov 17. Blood. 2006. PMID: 16293598 Free article.

4

Cationization of monoclonal antibodies: another step towards the "magic bullet"?

Vaisitti T, Deaglio S, Malavasi F. Vaisitti T, et al. J Biol Regul Homeost Agents. 2005 Jul-Dec;19(3-4):105-12. J Biol Regul Homeost Agents. 2005. PMID: 16602624 Review.

5

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Blood. 2006 Aug 15;108(4):1135-44. doi: 10.1182/blood-2006-01-013003. Epub 2006 Apr 18. Blood. 2006. PMID: 16621959 Free article. Review.

6

CD38/CD19: a lipid raft-dependent signaling complex in human B cells.

Deaglio S, Vaisitti T, Billington R, Bergui L, Omede' P, Genazzani AA, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Blood. 2007 Jun 15;109(12):5390-8. doi: 10.1182/blood-2006-12-061812. Epub 2007 Feb 27. Blood. 2007. PMID: 17327405 Free article.

7

Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.

D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L. D'Arena G, et al. Among authors: vaisitti t. Am J Hematol. 2007 Sep;82(9):787-91. doi: 10.1002/ajh.20936. Am J Hematol. 2007. PMID: 17534928 Free article.

8

CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.

Deaglio S, Vaisitti T, Aydin S, Bergui L, D'Arena G, Bonello L, Omedé P, Scatolini M, Jaksic O, Chiorino G, Efremov D, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Blood. 2007 Dec 1;110(12):4012-21. doi: 10.1182/blood-2007-06-094029. Epub 2007 Aug 15. Blood. 2007. PMID: 17699742 Free article.

9

CD38 at the junction between prognostic marker and therapeutic target.

Deaglio S, Aydin S, Vaisitti T, Bergui L, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Trends Mol Med. 2008 May;14(5):210-8. doi: 10.1016/j.molmed.2008.02.005. Epub 2008 Apr 9. Trends Mol Med. 2008. PMID: 18403265 Review.

10

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells.

Deaglio S, Aydin S, Grand MM, Vaisitti T, Bergui L, D'Arena G, Chiorino G, Malavasi F. Deaglio S, et al. Among authors: vaisitti t. Mol Med. 2010 Mar;16(3-4):87-91. doi: 10.2119/molmed.2009.00146. Epub 2009 Nov 20. Mol Med. 2010. PMID: 19956559 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters